Total (N = 143) | UC (N = 71) | APAD (N = 72) | ||||
---|---|---|---|---|---|---|
Age, mean (sd) | 51.6 | (10.1) | 52.1 | (9.3) | 51.2 | (10.9) |
Weight, mean (sd) | 68.5 | (13.9) | 69.6 | (14.1) | 67.5 | (13.7) |
BMI, mean (sd) | 25.5 | (5.3) | 25.8 | (5.3) | 25.2 | (5.4) |
Obese, N (%) | 26 | (18.2) | 15 | (21.1) | 11 | (15.3) |
Post-menopausal, N (%) | 67 | (46.8) | 37 | (52.1) | 30 | (41.7) |
Tobacco smoking, N (%) | ||||||
Non-smoker | 65 | (45.4) | 30 | (42.2) | 35 | (48.6) |
Smoker | 36 | (25.2) | 22 | (31.0) | 14 | (19.4) |
Former smoker | 42 | (29.4) | 19 | (26.8) | 23 | (31.9) |
Marital status, N (%) | ||||||
Single/divorced/widowed, no child | 3 | (2.1) | 2 | (2.8) | 1 | (1.4) |
Single/divorced/widowed, with child | 15 | (10.5) | 7 | (9.9) | 8 | (5.6) |
Married/Living together, no child | 7 | (4.9) | 3 | (4.2) | 4 | (2.8) |
Married/Living together, with child | 118 | (82.5) | 59 | (83.1) | 59 | (81.9) |
Education level, N (%) | ||||||
No qualifications | 23 | (16.1) | 14 | (19.7) | 9 | (12.5) |
Secondary level | 29 | (20.3) | 15 | (21.1) | 14 | (19.4) |
Completed high school | 31 | (21.7) | 11 | (15.5) | 20 | (27.8) |
Completed ≥2 years at University | 60 | (42.0) | 31 | (43.7) | 29 | (40.3) |
Usual professional status, N (%) | ||||||
Full or part-time employed | 95 | (66.4) | 43 | (60.5) | 52 | (72.2) |
Retired | 36 | (25.2) | 19 | (26.8) | 17 | (23.6) |
Unemployed/Medical leave | 12 | (8.4) | 9 | (12.7) | 3 | (4.2) |
Surgery type, N (%) | ||||||
Lumpectomy | 60 | (42.0) | 26 | (36.6) | 34 | (47.2) |
Quadrantectomy | 57 | (39.9) | 37 | (52.1) | 20 | (27.8) |
Mastectomy | 26 | (18.2) | 8 | (11.3) | 18 | (25.0) |
Cancer stagea, N (%) | ||||||
Stage I | 62 | (43.3) | 33 | (46.5) | 29 | (40.3) |
Stage IIa/IIb | 62 | (43.3) | 29 | (40.8) | 33 | (45.8) |
Stage IIIa/IIIc | 18 | (12.6) | 9 | (12.7) | 9 | (12.5) |
Breast cancer subtype, N (%) | ||||||
Triple negative | 32 | (22.4) | 13 | (18.3) | 19 | (26.4) |
HER2+, ER+, and/or PR+ | 17 | (11.9) | 9 | (12.7) | 8 | (11.1) |
HER2+, ER−, and PR− | 1 | (0.7) | 1 | (1.4) | 0 | (0.0) |
HER2-, ER+, and/or PR+ | 93 | (65.0) | 48 | (67.6) | 45 | (62.5) |